EGCG上調(diào)老年相關(guān)SERCA2a低表達(dá)的表觀遺傳機(jī)理研究
[Abstract]:Objective: cardiac diastolic dysfunction is a common cardiovascular disease in the elderly population, and the decreased expression of SERCA2a in the elderly heart is closely related to it. It was found that the expression of ATP2a2 gene was regulated by histone acetylation, while EGCG (epigallocatechin gallate) significantly affected the level of histone acetylation and regulated the transcription and expression of histone gene. Therefore, EGCG was used as an intervention method to investigate the effect of EGCG on the expression of SERCA2a in the heart of aged mice and its effect on cardiac histomorphology, and to explore its internal mechanism. Methods: 16-month-old male mice were randomly divided into EGCG elderly group, DMSO elderly group and untreated elderly group, 3-month-old male adult mice were young group, EGCG elderly mice were intraperitoneally injected with EGCG (50mg/kg/d), DMSO elderly group mice were intraabdominal injection and dissolved EGCG equal dose DMSO, intervention for 8 weeks, and cardiac tissue was collected. The results were as follows: (1) the expression of ATP2a2,HDAC1 and other genes m RNA in the heart of mice in each group was detected by RT PCR, and the expression of SERCA2a protein in the heart of mice in each group was detected by Western blot. 3. The histone H3 and H3K9, H3K4, H3K27 acetylated levels, histone deacetylase HDAC1 binding level, and the binding level of core transcription factor GATA4,Mef2c to ATP2a2 promoter region were detected by Ch IP-Q-PCR technique. 4. The ultrastructure of the heart was observed by transmission electron microscope, the degree of myocardial fibrosis was observed by Masson staining, and the apoptosis level of cardiomyocytes was detected by TUNEL assay. Results: 1the transcription and protein levels of EGCG in elderly group and youth group were significantly higher than those in DMSO elderly group and elderly group (p0.05). 2, compared with DMSO elderly group and elderly group, the expression of HDAC1m RNA and its binding to ATP2a2 gene promoter region in EGCG elderly group were significantly lower than those in ATP2a2 gene promoter group (p0.05). 3The histone H3 and H3K9 acetylation levels in the promoter region of ATP2a2 gene in the elderly group were significantly higher than those in the elderly group and the elderly group (p0.05), but there was no significant difference in the level of H3K4 acetylation among the three groups (p0.05). The acetylation level of H3K27 in the promoter region of the young group was higher than that in the other three groups (p0.05), but there was no significant difference among the three groups (p0.05). 4. The binding capacity of Mef2c to the promoter region of ATP2a2 gene in EGCG elderly group and young group was higher than that in DMSO elderly group and elderly group (p0.05). 5, myolysis and destruction of myocardial filaments, increase of collagen fibers and apoptosis of cardiomyocytes in aged group were higher than those in DMSO group (p0.05). In elderly group, the number of myocardial filaments dissolved and destroyed and the number of collagen fibers and cardiomyocytes in aged group decreased. Conclusion: 1ECG may inhibit the expression of cardiac histone deacetylase HDAC1, decrease its binding level to the promoter region of ATP2a2 gene, increase the acetylation level of ATP2a2 genomic protein H3K9 in aged mice, promote the binding of transcription factor GATA4,MEF2c, and up-regulate the low expression of SECA2a associated with the elderly. 2. The ultrastructure of myocardium was destroyed, myocardial fibrosis and cardiomyocyte apoptosis were increased in elderly mice. EGCG may improve this series of aging changes to a certain extent.
【學(xué)位授予單位】:重慶醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類(lèi)號(hào)】:R54
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 龐愛(ài)明,阮長(zhǎng)耿;綠茶的主要成分表沒(méi)食子兒茶素沒(méi)食子酸酯(EGCG)對(duì)血小板功能影響的研究[J];中國(guó)血液流變學(xué)雜志;2004年01期
2 梁鋼;林曉貞;唐安洲;黎莉;周銘;;EGCG對(duì)人耐藥口腔表皮樣癌細(xì)胞株耐藥逆轉(zhuǎn)的實(shí)驗(yàn)[J];腫瘤防治研究;2007年01期
3 龐愛(ài)明;阮長(zhǎng)耿;;綠茶的主要成分表沒(méi)食子兒茶素沒(méi)食子酸酯(EGCG)抗血液腫瘤血管新生機(jī)制的研究[J];中國(guó)血液流變學(xué)雜志;2008年04期
4 王輝;;粗茶多酚中的表沒(méi)食子兒茶素沒(méi)食子酸酯(EGCG)的提取方法研究[J];安徽農(nóng)業(yè)科學(xué);2008年21期
5 戚向陽(yáng);;EGCG氧化產(chǎn)物不同級(jí)分的分析及其抗氧化活性的研究[J];茶葉科學(xué);2008年06期
6 張衛(wèi)玉;呂俊杰;林翠英;謝美容;王章敬;王建新;王世鄂;;EGCG對(duì)昆明小鼠早胚體外發(fā)育的影響[J];解剖科學(xué)進(jìn)展;2010年02期
7 馬大鵬;;EGCG的純化及其應(yīng)用的研究新進(jìn)展[J];赤峰學(xué)院學(xué)報(bào)(自然科學(xué)版);2012年05期
8 魏冰;白厚增;楊則宜;;表沒(méi)食子兒茶素沒(méi)食子酸酯(EGCG)減肥機(jī)制的研究進(jìn)展[J];中國(guó)食品學(xué)報(bào);2012年03期
9 滕翠琴;龔受基;劉仲華;;綠茶成分EGCG抗腫瘤作用研究進(jìn)展[J];茶葉通訊;2012年04期
10 張媛媛;侯衛(wèi)平;袁發(fā);;EGCG對(duì)腎臟疾病保護(hù)作用的研究進(jìn)展[J];中國(guó)中西醫(yī)結(jié)合腎病雜志;2013年11期
相關(guān)會(huì)議論文 前10條
1 鄭紅發(fā);黃亞輝;黃懷生;;高EGCG茶的研究與開(kāi)發(fā)[A];湖南省茶葉優(yōu)勢(shì)區(qū)域建設(shè)會(huì)議暨湖南省茶葉學(xué)會(huì)2006年學(xué)術(shù)年會(huì)論文集[C];2006年
2 杜琪珍;沈星榮;蔣迎;;茶葉中EGCG的制備化分離新技術(shù)[A];海峽兩岸茶葉科技學(xué)術(shù)研討會(huì)論文集[C];2000年
3 陳偉強(qiáng);李樹(shù)田;侯s,
本文編號(hào):2501972
本文鏈接:http://sikaile.net/yixuelunwen/xxg/2501972.html